Multiple Dates

Sight. Sound. Cycle. - Deerfield, Illinois

Event Information

Share this event

Date and Time



WheelPower Studio

49 Waukegan Rd

Deerfield, IL 60015

View Map

Event description


A different kind of fundraiser, fun & active!

We are spinning for a great cause. Raising money and awareness for Usher Syndrome Type 1F. We MUST find a cure, so come and spin.

Expert, beginner, wannabe spinner, doesn’t matter your level, we are spinning for Zachary Root and others with Usher Syndrome. 100% of proceeds goes directly for research through the Usher 1f Collaborative, a 501(c)3 organization.


What is Usher Syndrome

Usher Syndrome is the leading cause of deaf-blindness in the world. The major symptoms of Usher syndrome are hearing loss, poor balance and an eye disorder called retinitis pigmentosa, or RP. RP first causes night-blindness, then loss of peripheral vision, and eventually total blindness through the progressive degeneration of the retina. Type 1 is the most severe, with deafness and poor balance from birth and symptoms of retinitis pigmentosa beginning in the first decade of life. Thankfully, through the use of cochlear implants, children born today with Usher Syndrome 1F are given access to sound at an early age and are able to learn how to listen and speak. There is currently NO CURE or treatment to save their vision.

Usher syndrome is inherited, which means it is passed from parents to their children through genes. As many as 5% of Ashkenazi Jews carry the genetic mutation for Usher Syndrome and about 2.5% carry the Usher 1F mutation. When both parents carry the mutation, there is a 25% chance they will have a child with Usher syndrome.

Sustainable Pathway to a Cure

Investing in research will enable Usher 1F Collaborative to continue to fund the medical researchers who are currently working to cure Usher 1F and to expand our work and engage additional retinal researchers.

Edwin Stone, M.D., Ph.D., at the University of Iowa Wynn Institute for Vision Research, is developing gene replacement therapy, a technique used successfully for other types of retinitis pigmentosa, to replace the mutated gene in the eye, as well as stem cell therapy using patients’ own skin cells, to halt further progression of vision loss and restore lost vision.

Monte Westerfield, Ph.D., at the University of Oregon Institute Of Neuroscience, has developed a zebrafish model of the Usher 1F mutation and is about to begin testing of drugs that hold the potential to halt or slow the progression of vision loss.

Zubair Ahmed, Ph.D., at the University of Maryland, has develop a mouse model of the Usher 1F mutation that he is now using both to test potential drug treatments in collaboration with Dr. Westerfield and to develop gene replacement therapy for Usher 1F.

Livia Carvalho, Ph.D., at the University of Western Australia, is collaborating with Dr. Ahmed to develop gene replacement therapy for Usher 1F.

Investing in a Solution

To date our organization has raised almost $1 million and granted $700,000 to these top researchers. They are making excellent progress toward a treatment for Usher 1F, adapting gene therapy treatments already either in clinical trial or proven in the lab for other types of Usher Syndrome and retinitis pigmentosa.

A clinical trial is now no longer a dream but a likely reality within the next five years!

Share with friends


WheelPower Studio

49 Waukegan Rd

Deerfield, IL 60015

View Map

Save This Event

Event Saved